Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade C 333.8 1.05% 3.48
ABMD closed up 1.91 percent on Thursday, January 17, 2019, on 47 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Earnings due: Jan 31

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Jan 17 Crossed Above 50 DMA Bullish 1.05%
Jan 16 50 DMA Resistance Bearish 2.98%
Jan 15 MACD Bullish Centerline Cross Bullish 2.52%
Jan 14 MACD Bearish Centerline Cross Bearish 5.88%
Jan 14 Stochastic Sell Signal Bearish 5.88%
Jan 14 Narrow Range Bar Range Contraction 5.88%
Jan 14 NR7 Range Contraction 5.88%
Jan 14 Overbought Stochastic Strength 5.88%
Jan 14 Down 3 Days in a Row Weakness 5.88%
Jan 11 Fell Below 50 DMA Bearish 3.09%

Older signals for ABMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 459.75
52 Week Low 219.13
Average Volume 626,716
200-Day Moving Average 365.9867
50-Day Moving Average 325.4872
20-Day Moving Average 313.383
10-Day Moving Average 323.73
Average True Range 15.2417
ADX 14.85
+DI 26.7857
-DI 21.5252
Chandelier Exit (Long, 3 ATRs ) 297.2449
Chandelier Exit (Short, 3 ATRs ) 319.7451
Upper Bollinger Band 344.2023
Lower Bollinger Band 282.5637
Percent B (%b) 0.77
BandWidth 19.668776
MACD Line 1.5552
MACD Signal Line -1.0531
MACD Histogram 2.6083
Fundamentals Value
Market Cap 14.58 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 193.17
Price-to-Sales 16.68
Price-to-Book 13.96
PEG Ratio 2.75
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 343.64
Resistance 3 (R3) 343.03 337.99 341.42
Resistance 2 (R2) 337.99 334.59 338.29 340.68
Resistance 1 (R1) 334.15 332.50 336.07 334.76 339.94
Pivot Point 329.11 329.11 330.07 329.41 329.11
Support 1 (S1) 325.27 325.71 327.19 325.88 320.70
Support 2 (S2) 320.23 323.62 320.53 319.96
Support 3 (S3) 316.39 320.23 319.22
Support 4 (S4) 317.00